S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

FHTX Foghorn Therapeutics Inc

4.36

-0.11 (-2.46%)

26 Apr 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Foghorn Therapeutics (NASDAQ:FHTX)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Foghorn Therapeutics Charts.

Foghorn Therapeutics (NASDAQ:FHTX)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Foghorn Therapeutics Charts.

Foghorn Therapeutics Inc News

Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction with 2025 AACR Annual Meeting
Tuesday 15 April 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 11 April 2025 (2 weeks ago) • Edgar (US Regulatory)

Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting
Wednesday 26 March 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 25 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 21 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 21 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 7 March 2025 (2 months ago) • Edgar (US Regulatory)

Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook
Friday 7 March 2025 (2 months ago) • GlobeNewswire Inc.

Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
Tuesday 25 February 2025 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 3 February 2025 (3 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Monday 3 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 January 2025 (3 months ago) • Edgar (US Regulatory)

More Foghorn Therapeutics Inc News Articles

BNP Paribas Issuance

Societe Generale Effekten

Societe Generale Effekten

Societe Generale Effekten

Vontobel Financial Produ...

EURO STOXX 50 +3X Daily ...

Societe Generale Effekten

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions